Funding Tracker/Thyme Care
Series E · Oncology Care · United States
Thyme Care raises $125M
Announced September 2, 2026
The round
Thyme Care announced a Series E round of $125M on September 2, 2026, led by Morgan Health. Other participants include Humana, CVS Health Ventures.
The SignalOncology navigation past $2B valuation; launches Thyme Companies parent for new oncology businesses.
What Thyme Care does
Provides oncology care navigation and support to improve patient outcomes and lower costs.
Thyme Care operates a technology-enabled oncology care management platform. The company partners with health plans and risk-bearing providers to guide cancer patients through their treatment journeys, offering 24/7 access to clinical teams who coordinate care and manage side effects.
Full Thyme Care profile- Company
- Thyme Care
- Amount
- $125M
- Stage
- Series E
- Announced
- September 2, 2026
- Led by
- Morgan Health
- Other investors
- Humana, CVS Health Ventures
- Vertical
- Oncology Care
- Country
- United States
- Headquarters
- Nashville, United States
- Founded
- 2020